Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Healthy Japanese”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01293383
What this trial is testing

A Study Evaluating the Safety of LEO 90105 and Its Vehicle, After Multiple Administration on Intact Skin of Healthy Japanese Male Subjects

Who this might be right for
Healthy
LEO Pharma 12
Early research (Phase 1)Study completedNCT06310005
What this trial is testing

A Study in Healthy Japanese Men to Test How Well Different Doses of BI 3006337 Are Tolerated

Who this might be right for
Healthy
Boehringer Ingelheim 36
Early research (Phase 1)WithdrawnNCT00947245
What this trial is testing

Japanese Bridging Study Conducted in the United States

Who this might be right for
Hepatitis C Virus
Bristol-Myers Squibb
Early research (Phase 1)Study completedNCT00766012
What this trial is testing

Study to Assess the Safety, Tolerability and Pharmacokinetics After Multiple Doses of AZD2066 in Japanese Subjects

Who this might be right for
Healthy
AstraZeneca 132
Early research (Phase 1)Ended earlyNCT02209506
What this trial is testing

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MLN3126 in Healthy Japanese and Non-Japanese Participants

Who this might be right for
SafetyTolerabilityPharmacokinetics+1 more
Takeda 23
Early research (Phase 1)Study completedNCT02853435
What this trial is testing

To Assess Bioavailability, Food Effect and Pharmacokinetics of Gepotidacin Tablets: A Phase I, Single-Dose, 2 Part Study in Healthy Subjects.

Who this might be right for
Infections, Bacterial
GlaxoSmithKline 48
Early research (Phase 1)Study completedNCT01448317
What this trial is testing

Ascending Dose Study of the Safety and Tolerability of Alirocumab (SAR236553/REGN727) in Japanese Healthy Volunteers

Who this might be right for
Hypercholesterolemia
Sanofi 32
Early research (Phase 1)Study completedNCT03159455
What this trial is testing

This Study Tests BI 1467335 in Healthy Japanese and Caucasian Men. The Study Tests How Different Doses of BI 1467335 Are Taken up in the Body and How Well They Are Tolerated

Who this might be right for
Healthy
Boehringer Ingelheim 48
Early research (Phase 1)Study completedNCT01506752
What this trial is testing

A Bioequivalence Study Comparing Improved Versus Current Orally Disintegrating E2020 10 mg Tablet in Healthy Japanese Adult Males

Who this might be right for
Healthy Adult
Eisai Co., Ltd. 20
Early research (Phase 1)Study completedNCT03398876
What this trial is testing

Assess the Nicotine Pharmacokinetics, Tolerability and Safety With a New Oral Nicotine Replacement Product in Healthy Japanese Smokers

Who this might be right for
Healthy
Janssen Pharmaceutical K.K. 24
Large-scale testing (Phase 3)Study completedNCT01200368
What this trial is testing

Trial Evaluating a 13-valent Pneumococcal Conjugate Vaccine Given With Diphtheria, Tetanus, and Acellular Pertussis Vaccine (DTaP) in Healthy Japanese Infants

Who this might be right for
Healthy Subjects
Pfizer 551
Early research (Phase 1)Study completedNCT00551317
What this trial is testing

A Study Investigating the Concentrations of Darapladib in Blood and the Safety of This Compound in Healthy Japanese Men

Who this might be right for
Atherosclerosis
GlaxoSmithKline 18
Early research (Phase 1)Ended earlyNCT00945425
What this trial is testing

AZD7325 Japan Multiple Ascending Dose (MAD) Study

Who this might be right for
Healthy
AstraZeneca 48
Early research (Phase 1)Study completedNCT03133468
What this trial is testing

Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AJM347 in Healthy Male Caucasian and Japanese Subjects in the Fasted and Fed State

Who this might be right for
Healthy Participants
EA Pharma Co., Ltd. 200
Post-approval studies (Phase 4)Study completedNCT04588480
What this trial is testing

Study to Evaluate the Safety, Tolerability, and Immunogenicity of an RNA Vaccine Candidate Against COVID-19 in Healthy Japanese Adults

Who this might be right for
SARS-CoV-2 InfectionCOVID-19
BioNTech SE 160
Post-approval studies (Phase 4)Study completedNCT02530060
What this trial is testing

Evaluate the Pharmacokinetics of Rilpivirine/Tenofovir/Emtricitabine After a Single-Oral Administration in Healthy Japanese Adult Male Participants

Who this might be right for
Healthy
Janssen Pharmaceutical K.K. 8
Early research (Phase 1)Study completedNCT02415790
What this trial is testing

Study to Assess the Safety, Tolerability, Pharmacokinetics of E2027 in Healthy Adult and Elderly Subjects, and the Pharmacodynamics in Healthy Adult Subjects

Who this might be right for
Healthy Participants
Eisai Inc. 112
Early research (Phase 1)Study completedNCT01415778
What this trial is testing

Bioequivalence of ICI176,334-1 in Japanese Healthy Male Subjects

Who this might be right for
Healthy
AstraZeneca 48
Early research (Phase 1)Study completedNCT03536325
What this trial is testing

Assess the Safety, Tolerability and Pharmacokinetics of Guselkumab Following a Single Intravenous Administration in Healthy Japanese Participants

Who this might be right for
Healthy
Janssen Pharmaceutical K.K. 24
Early research (Phase 1)Study completedNCT05099133
What this trial is testing

A Trial to Evaluate Pharmacokinetics, Immunogenicity, Safety, and Tolerability of LEO 138559 in Healthy Japanese Subjects

Who this might be right for
Atopic Dermatitis
LEO Pharma 24
Next Page